The Growth Enhancement Potentials of Indigenous Plant Growth Promoting Rhizobacteria on Sweet Pepper (Caspicum annum) through Seed Bacterization

The demand for food is rising as the world's population is rising. The second sustainable development goal's objectives of achieving global food security and agricultural sustainability call for swift and coordinated action. The use of traditional mineral fertilizers has increased dramatically in response to the rise in food demand, but this has its drawbacks. Plant growth-promoting rhizobacteria (PGPR) which is a free-living bacteria actively colonize plant roots and aids it growth. They provide an environmentally friendly way to boost plant output. Due to the  high nutritional content and wide range of medicinal applications of sweet pepper (Capsicum annuum L.), it constitute one of the most significant vegetable crops in the world.. sweet pepper (Capsicum annum ) was evaluated through a pot study under the treatment of six bacterial strains. Bacterization of sweet pepper seeds was done via the immersion of seeds in a suspension of bacteria (108 CFU/ml) modified with 2% carboxymethyl cellulose (CMC), The treated seeds were planted in sterilized planting bags with sterilized sand, Effects of bacterized seeds of Capsicum annuum on the shoot height revealed that the highest shoot height was observed at week 8 by isolate AU4(Burkholderia sp) at (9.66±12.15), followed by AU6 (Burkholderia sp ) at week 6 (6.26±0.05). The highest leaf number of Capsicum annuum after bacterization was observed at week 8(9.00±0.0) and 10(9.00±0.0), while the observed control at week 8(6.00±1.0) week 10(7.00±0.0). Plant growth-promoting bacteria applied via seed bacterization has shown potential for increasing the growth parameters of sweet pepper. This could be a formidable substitute for the use of chemical fertilizers. The use of Burkholderia vietnamiensis AU2011 and Burkholderia sp have shown potential for the increment of the agronomical parameter of  C. annuum

Faecal microbial transplant

Faecal Microbial Transplantation (FMT), have been shown to be successfully managed along with a variety of gastrointestinal disorders, including Clostridioides difficile infection (CDI), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). FMT is a medical procedure that involves a donor transferring healthy gut bacteria to the recipient. The effectiveness of FMT is thought to be due to the ability of the healthy gut to restore balance to the recipient's microbiome, which is the community of microorganisms that inhabit the gastrointestinal tract. One of the key advantages of FMT is that it is a relatively simple and low-cost treatment option, compared to other therapies that may be more invasive or require long-term medication use. However, FMT is not without its limitations, including the potential for the transfer of infectious agents from the donor to the recipient and the potential for negative side effects in some patients. In this research, we discuss the current state of the evidence on FMT, including its potential benefits and risks, as well as future directions for research in this area